North America Vitamin K2 Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Vitamin K2 Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Vitamin K2 Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of CVD
5.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns

5.2 Market Opportunities

5.2.1 Expansion of Distribution Channel

5.3 Future Trends

5.3.1 Regulatory Consideration and Standards

5.4 Impact of Drivers and Restraints

6. North America Vitamin K2 Market Regional Analysis

6.1 North America Vitamin K2 Market Overview

6.2 North America Vitamin K2 Market Revenue 2020-2030 (US$ Million)

6.3 North America Vitamin K2 Market Forecast Analysis

7. North America Vitamin K2 Market Analysis – by Product

7.1 MK-4

7.1.1 Overview
7.1.2 MK-4: North America Vitamin K2 Market – Revenue and Forecast to 2031 (US$ Million)

7.2 MK-7

7.2.1 Overview
7.2.2 MK-7: North America Vitamin K2 Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Combination Drugs

7.3.1 Overview
7.3.2 Combination Drugs: North America Vitamin K2 Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Vitamin K2 Market Analysis – by Dosage Forms

8.1 Capsules & Tablets

8.1.1 Overview
8.1.2 Capsules & Tablets: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Powder

8.2.1 Overview
8.2.2 Powder: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Oils

8.3.1 Overview
8.3.2 Oils: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Vitamin K2 Market Analysis – by Source

9.1 Natural

9.1.1 Overview
9.1.2 Oils: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Synthetic

9.2.1 Overview
9.2.2 Oils: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Vitamin K2 Market – North America Analysis

10.1 North America

10.1.1 North America Vitamin K2 Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Vitamin K2 Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Vitamin K2 Market Breakdown, by Product
10.1.1.1.2 US: North America Vitamin K2 Market Breakdown, by Dosage Forms
10.1.1.1.3 US: North America Vitamin K2 Market Breakdown, by Source

10.1.1.2 Canada: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Vitamin K2 Market Breakdown, by Product
10.1.1.2.2 Canada: North America Vitamin K2 Market Breakdown, by Dosage Forms
10.1.1.2.3 Canada: North America Vitamin K2 Market Breakdown, by Source

10.1.1.3 Mexico : North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Vitamin K2 Market Breakdown, by Product
10.1.1.3.2 Mexico : North America Vitamin K2 Market Breakdown, by Dosage Forms
10.1.1.3.3 Mexico : North America Vitamin K2 Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Vitamin K2 Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Anderson Global Group LLC

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Balchem Corp

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 BASF SE

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Glanbia Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 International Flavors & Fragrances Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Koninklijke DSM NV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Lesaffre et Cie SA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Lonza Group AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Novozymes AS

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights